abstract |
The use of an IL-18 inhibitor for the manufacture of a pharmaceutical composition for the treatment and / or prevention of atherosclerosis. The present invention also provides the use of a vector comprising an IL-18 inhibitor coding sequence for the manufacture of a pharmaceutical composition for the same purpose, as well as the use of transfected cells containing such a vector. |